Significant role of genetics in IBD: the NOD2 gene
- PMID: 12684585
Significant role of genetics in IBD: the NOD2 gene
Abstract
Inflammatory bowel disease (IBD) clusters within families, suggesting a genetic component to disease pathogenesis. Studies have identified a gene on chromosome 16cen that confers susceptibility to Crohn's disease. The affected gene codes for the NOD2/CARD15 protein, which is involved in the immune system's response to bacterial infection. Multiple mutations have been identified, three of which have been shown to be independently associated with Crohn's disease-arg702trp, gly908arg, and leu1007fsinsC. Taken together, these three variants confer a 15%-20% attributable population risk among cases of familial Crohn's disease, with decreased contribution among the more common sporadic cases of the disease. The presence of an NOD2 risk allele has been shown to be associated with ilial disease as well as an earlier age of disease onset. Further studies are needed to clarify the relationship between IBD genotype and disease behavior.
Similar articles
-
Variation at NOD2/CARD15 in familial and sporadic cases of Crohn's disease in the Ashkenazi Jewish population.Am J Gastroenterol. 2002 Dec;97(12):3095-101. doi: 10.1111/j.1572-0241.2002.07105.x. Am J Gastroenterol. 2002. PMID: 12492195
-
NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease.Am J Gastroenterol. 2004 Jun;99(6):1134-40. doi: 10.1111/j.1572-0241.2004.04156.x. Am J Gastroenterol. 2004. PMID: 15180737
-
Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.Eur J Gastroenterol Hepatol. 2007 Mar;19(3):217-23. doi: 10.1097/01.meg.0000250590.84102.12. Eur J Gastroenterol Hepatol. 2007. PMID: 17301648
-
CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.Eur J Gastroenterol Hepatol. 2007 Jun;19(6):449-59. doi: 10.1097/01.meg.0000236887.44214.6a. Eur J Gastroenterol Hepatol. 2007. PMID: 17489054 Review.
-
Inflammatory bowel disease: Crohn's disease and the success of NODern genetics.Clin Invest Med. 2003 Dec;26(6):303-14. Clin Invest Med. 2003. PMID: 14690304 Review.
Cited by
-
CARD15/NOD2 in a Tunisian population with Crohn's disease.Dig Dis Sci. 2005 Jan;50(1):130-5. doi: 10.1007/s10620-005-1290-0. Dig Dis Sci. 2005. PMID: 15712650
-
Novel pathophysiological concepts of inflammatory bowel disease.J Gastroenterol. 2006 Jan;41(1):10-6. doi: 10.1007/s00535-005-1744-3. J Gastroenterol. 2006. PMID: 16501852 Review. No abstract available.
-
Crohn's disease: a review of current treatment with a focus on biologics.Drugs. 2007;67(17):2511-37. doi: 10.2165/00003495-200767170-00005. Drugs. 2007. PMID: 18034589 Review.
-
NOD2 mutations affect muramyl dipeptide stimulation of human B lymphocytes and interact with other IBD-associated genes.Dig Dis Sci. 2013 Sep;58(9):2599-607. doi: 10.1007/s10620-013-2696-8. Epub 2013 May 26. Dig Dis Sci. 2013. PMID: 23709157
-
1007fs, G908R, R702W mutations and P268S, IVS8+158 polymorphisms of the CARD15 gene in Turkish inflammatory bowel disease patients and their relationship with disease-related surgery.Dig Dis Sci. 2008 Jun;53(6):1683-92. doi: 10.1007/s10620-007-0054-4. Dig Dis Sci. 2008. PMID: 17978873